Skip to main content
Knowledge we build together Honest and transparent Real people, real data

Diabetes medications: how the drug classes work

Type 2 diabetes can be influenced at many points in metabolism, so there are several drug classes, each acting at a different place. A factual overview; the choice is always made by your care team.

Author: StoffwechselFit editorial teamLast updated: 21 Jul 2026

🌐 Translated from the German original. Wording has been localised for English readers; in case of doubt, the German version is authoritative.

Individual illustration: Diabetes medications: how the drug classes work
Diabetes medications: how the drug classes work

Diabetes medications overview illustration Warm, matter-of-fact scene with tablets and an insulin pen as symbols for the different treatment options in diabetes. Tablets Pen / injection How the drugs work A factual overview of the main drug classes. For orientation, the choice is always made by the care team.
For orientation, the choice is always made by the care team.

Why there are so many classes

Blood sugar can be influenced in several places: at the liver’s sugar release, at insulin secretion, at insulin action, at sugar excretion through the kidney, or at digestion. Each drug class works at a different point, which is why they can often be sensibly combined.

The main drug classes in type 2 diabetes Overview of five groups and how they work. Metformin lowers the liver’s sugar output and is usually first choice. SGLT2 inhibitors let excess sugar be excreted via the urine and protect the heart and kidneys. GLP-1 receptor agonists increase insulin release after eating, curb appetite and protect the heart. Sulfonylureas stimulate the pancreas to release insulin but can cause hypos. Insulin replaces or supplements the body’s own insulin. The main drug classes Simplified: many further classes and combinations exist MetforminLowers the liver’s sugar release · usually first choice SGLT2 inhibitorsSugar is excreted via urine · protects heart & kidneys GLP-1 receptor agonistsMore insulin after eating, less appetite · protects the heart SulfonylureasStimulate insulin release · can cause hypos InsulinReplaces or supplements the body’s insulin · always needed in type 1
Fig. 1: The main drug classes in type 2 diabetes and where each acts (much simplified).

The classes in detail

Metformin mainly lowers the liver’s sugar release and improves insulin action. In type 2 it’s usually the first medication, well established, and on its own it barely causes hypoglycaemia.

SGLT2 inhibitors cause excess sugar to be excreted via the urine. Beyond blood sugar, several of these agents protected the heart and kidneys in studies, which is why they’re now also used with corresponding comorbidities.

GLP-1 receptor agonists boost insulin secretion after eating, curb appetite and slow gastric emptying. Many people lose weight on them; some agents also showed cardiovascular protection.

DPP-4 inhibitors work on a related pathway to the GLP-1 drugs, usually as a tablet and weight-neutral.

Sulfonylureas directly stimulate the pancreas to release insulin. They work reliably but, unlike most newer agents, can cause hypoglycaemia.

Insulin replaces or supplements the body’s own insulin. In type 1 it’s always necessary; in type 2 it’s used when other agents are no longer enough.

Key takeaways

  • Different drug classes act at different points and can often be combined.
  • Metformin is usually first choice in type 2.
  • SGLT2 inhibitors and GLP-1 receptor agonists can also benefit heart, kidneys and weight.
  • Sulfonylureas and insulin can cause hypoglycaemia.
  • The choice is always made by the care team – individual and depending on comorbidities.

Article ID: SWF-W-008Please quote this ID for corrections or additions.

Sources

Sources as of: 21 Jul 2026.

  1. Pharmacological approaches to glycaemic treatment; drug classes and cardiorenal benefits. ADA Standards of Care. diabetesjournals.org (opens in a new window)
  2. Medications for type 2 diabetes: classes, effects, hypoglycaemia risk. IQWiG / Gesundheitsinformation. gesundheitsinformation.de (opens in a new window)
  3. Overview of diabetes medications and how they act. Diabinfo. diabinfo.de (opens in a new window)

Medical note: General, source-informed information for orientation, not medical advice. This is not a dosing guide; the choice, dosing and combination of medications belong in medical hands. No promise of cure.

Share

These are plain links — no tracking scripts are loaded.